The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125446441 12544644 1 I 20160704 20160711 20160711 EXP US-MYLANLABS-2016M1028545 MYLAN FRIEDMAN MD, LACOUTURE M, DANG C. DERMATOLOGIC ADVERSE EVENTS ASSOCIATED WITH USE OF ADJUVANT LAPATINIB IN COMBINATION WITH PACLITAXEL AND TRASTUZUMAB FOR HER2-POSITIVE BREAST CANCER: A CASE SERIES ANALYSIS. CLIN-BREAST-CANCER 2016;16(3):E69-E74. 0.00 Y 0.00000 20160711 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125446441 12544644 1 PS PACLITAXEL. PACLITAXEL 1 Unknown EVERY OTHER WEEK FOR 4 CYCLES 91540
125446441 12544644 2 I LAPATINIB LAPATINIB 1 Oral DAILY 0
125446441 12544644 3 I TRASTUZUMAB TRASTUZUMAB 1 Unknown WEEKLY U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125446441 12544644 1 Invasive ductal breast carcinoma
125446441 12544644 2 Invasive ductal breast carcinoma
125446441 12544644 3 Invasive ductal breast carcinoma

Outcome of event

Event ID CASEID OUTC COD
125446441 12544644 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125446441 12544644 Dermatitis acneiform
125446441 12544644 Drug interaction
125446441 12544644 Rash maculo-papular
125446441 12544644 Staphylococcal infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found